Niger vs SEAR: Hepatitis B surface antigen (HBsAg) prevalence
Niger
3.2%
in 2024
SEAR
0.2%
in 2024
Niger rank
3rd
SEAR rank
5th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Niger
- SEAR
How they compare
Niger currently reports 3.2% against 0.2% in SEAR, a difference of 3.0%.
That makes Niger's figure about 16.0 times SEAR's.
Across all 10 years both countries report, Niger has been ahead every year.
Niger ranks 3rd and SEAR ranks 5th of 194 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Niger | SEAR | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 0.4% | 2.2% | Niger |
| 2020s | 3.4% | 0.3% | 3.2% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Niger or SEAR?
- Niger, at 3.2% against 0.2% in SEAR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Niger and SEAR?
- 3.0%, with Niger ahead.
- How many years of comparable data are there for Niger and SEAR?
- 10 years are reported by both, from 2015 to 2024.
- How do Niger and SEAR rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Niger ranks 3rd and SEAR ranks 5th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.